Interview | Decentralisation, AI & Sustainability: The New Pillars of Clinical Trials [updated Oct 2025]

As 2026 approaches, the clinical trials landscape is evolving rapidly—driven by innovative technologies, shifting patient needs, and a strong push for global inclusion. In this exclusive interview, Steve Jacobs, President of Global BioPharm Solutions, LLC, explains how clinical trial supply chains are being reshaped by new challenges and opportunities. From the rise of AI and automation to the shift towards decentralised, patient-centric trials, Steve offers valuable insights on how the industry can not only adapt but thrive.

Discover how embracing cutting-edge technology, reinforcing data integrity, and championing sustainability will future-proof clinical operations in a complex, diverse world.

Download the interview to learn more about:

• AI & Automation: Revolutionising trials by speeding up development, boosting efficiency, and enhancing data quality.
• Decentralisation & Patient-Centric Models: Elevating trial operations through improved enrolment and retention.
• Sustainability & Global Inclusion: Integrating greener practices while ensuring accessibility for diverse populations.